Funding
← Back to your selection

Catalio Capital Management

Activity from announced rounds

Activity in this selectionUnited States · Oct 14, 2026 · Sep 15, 2026
Rounds participated in
2
Confirmed lead rounds
1
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$115M
2 disclosed · full round size, not this investor’s share

By stage

Series B1
Series C+1

By primary sector

Biotech1
Healthtech1

By country

United States2

Rounds

2 in this selection
BigHat Biosciences

An AI and synthetic-biology platform that designs and engineers antibody therapeutics.

$75MSeries C
Participant
Evvy

Evvy combines at-home vaginal microbiome testing with clinician-reviewed results, personalized next steps and optional treatment and coaching for women’s health.

$40MSeries B
Lead